Can Oxcarbazepine 300 mg Tablets Be Crushed for Feeding Tube Administration?
Yes, oxcarbazepine immediate-release tablets can be crushed and administered through a feeding tube, but this practice should be avoided whenever possible in favor of the commercially available oral suspension formulation (60 mg/mL). 1
Preferred Formulation
- A liquid oral suspension of oxcarbazepine (60 mg/mL; 6%) is commercially available and registered worldwide, making it the strongly preferred option for feeding tube administration. 1
- Liquid formulations reduce the risk of tube occlusion, improve dosing accuracy, and limit occupational drug exposure compared to crushed tablets. 2, 3
If Crushing Is Necessary
Pre-Administration Requirements
- Consult a pharmacist before crushing to confirm appropriateness, verify proper technique, and ensure the product label does not prohibit the procedure. 4, 2
- Crushing tablets constitutes off-label use and carries additional legal responsibility under the Summary of Product Characteristics. 4, 5
- Crushing medications increases the risk of occupational drug exposure to healthcare workers and may lead to inaccurate dosing. 2, 3
Proper Administration Technique
- Flush the feeding tube with at least 30 mL of water before administering the crushed medication. 4, 2
- Administer each medication individually through the tube—never mix multiple drugs together before administration. 4, 2
- Flush the tube with 30 mL of water immediately after medication delivery. 4, 2
- If multiple medications are given sequentially, flush with 30 mL of water between each drug to minimize tube blockage. 4, 2, 5
Equipment Standards
- Use ENFit-standard syringes and connectors for all enteral administrations to prevent fatal misconnection errors. 2, 3, 5
- Do not shake low-dose ENFit syringes to dislodge residue, as this exposes staff to the drug and alters the delivered dose. 2, 3, 5
Important Clinical Considerations
Absorption and Bioavailability
- Oxcarbazepine immediate-release tablets have almost complete bioavailability when administered orally. 1, 6
- The site of feeding tube tip placement matters: gastric delivery (standard G-tube or NG tube into stomach) typically provides adequate absorption, but administration distal to the stomach may reduce drug efficacy. 4, 2
- Oxcarbazepine is rapidly reduced by cytosolic hepatic enzymes to its active metabolite (MHD), which is responsible for the pharmacological effect. 1, 7
Tube Occlusion Risk
- Crushed solid dosage forms are associated with a higher incidence of feeding tube occlusions compared to liquid formulations. 4, 5
- Adequate flushing with at least 30 mL of water before, between, and after medications is essential to prevent tube blockage. 4
Drug-Formula Interactions
- Verify potential interactions between oxcarbazepine and the enteral nutrition formula, as certain medications may bind to formula components and should be administered separately from the feed. 4, 5
- The site of drug delivery and timing relative to enteral feeding can significantly affect drug efficacy. 4, 2
Common Pitfalls to Avoid
- Do not use the extended-release formulation (Apydan extent) for crushing, as this would destroy the controlled-release mechanism and is not addressed in the available evidence. 6
- More than 30% of caregivers receive no instruction on proper medication administration through feeding tubes, underscoring the critical need for targeted education. 4, 5
- Limited knowledge among healthcare providers about feeding tube medication administration is widespread—pharmacist involvement is essential. 4